CONSORT flow diagram. by Judith I. Tsui (5983160)

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

The influence of the controlled pH conditions at the sample preparation step on the obtained signals (panel A: extraction using a mixture of MeOH and EtOH; panel B: extraction usin... by Ewa Paszkowska (21246702)

Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Random forest plot showing the importance of predictors (top 10) for classifying LF progression based on the Mean Decrease in Gini index. by Emmanuel Kobla Atsu Amewu (13946765)

Increases in temperature for the two drill systems at different positions using different drilling procedures. The data in bold indicate the position where the highest mean tempera... by Marsel Ganeyev (21453399)

Increases in temperature for the two drill systems at different positions using different drilling procedures and feed rates. The data in bold indicate the position where the highe... by Marsel Ganeyev (21453399)

Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase. by Basmah Safdar (12213257)

Variants enriched in an <i>Ae</i>. <i>aegypti</i> cell line <i>(</i>Aag2) have increased fitness in Aag2 cells but decreased fitness in a human cell line (MRC-5). by Chelsea Cereghino (15188341)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Outcome measures on step 5. by Timmion K. Skervin (11432568)

Subjects:

Oral administration of TVSE decreases angiogenesis in 4T1 tumors in BALB/c mice. by Hyun Sook Lee (8039876)

Data Supplement from Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis by Naoharu Takano (15079957)

S10 and T3SS reporter signals do not correlate in the absence of MgOx treatment. by Justin Greene (306625)

Mean squared error of estimates decreases with larger datasets. by Alexander Eugene Zarebski (12078347)

“…<p>The mean squared error in the estimates of under the posterior distribution decreases as the size of the dataset increases. …”

Feature importance of the extracted characteristics from the simulation using Mean Decrease in Impurity (MDI). by Simon Bin Akter (17951860)

Mean decrease Gini score by Tweet and user characteristics. by Gray Babbs (16648894)